Release according to article 40 para. 1 WpHG
Medigene AG: Correction of a Release according to Article 40, Section 1 of the WpHG from 16.11.2020
City, Post Code (EN) (pta034/18.11.2020/20:30 UTC+1) - Release of Voting Rights Announcement
Voting Rights Announcement
1. Details of issuer
| Name: | Medigene AG |
| Legal Entity Identifier (LEI): | 391200I33JD2DKZGDX06 |
| Street: | Lochhamer Straße 11 |
| Postal code: | 82152 |
| City: | Planegg/Martinsried, Germany |
2. Reason for notification
Acquisition / disposal of shares with voting rights
3. Details of person subject to the notification obligation
Legal entity: Aviva Plc.
City and country of registered office:
London,
United Kingdom
4. Names of shareholders holding directly 3% or more voting rights, if different from 3.
5. Date on which threshold was crossed or reached
13.11.2020
6. Total positions
| % of voting rights attached to shares (total of 7.a.) | % of voting rights through instruments (total of 7.b.1 + 7.b.2) | Total of both in % (7.a. + 7.b.) | Total number of voting rights pursuant to Sec. 41 WpHG | |
|---|---|---|---|---|
| New | 2.67 | 0.00 | 2.67 | 24,562,658 |
| Previous notification (if applicable) | 0.00 | 0.00 | 0.00 |
7. Details on total positions
a. Voting rights attached to shares (Sec.s 33, 34 WpHG)
| ISIN | Absolute direct (Sec. 33 WpHG) | Absolute indirect (Sec. 34 WpHG) | In % direct (Sec. 33 WpHG) | In % indirect (Sec. 34 WpHG) |
|---|---|---|---|---|
| DE000A1X3W00 | 0 | 657,051 | 0.00 | 2.67 |
| Total: | 657,051 | 2.67 |
b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
| type of instrument | Maturity / Expiration | Exercise or conversion period | Voting Rights Absolute | Voting Rights in % |
|---|---|---|---|---|
| Total: |
b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
| type of instrument | Maturity / Expiration | Exercise or conversion period | Cash or physical transaction | Voting Rights Absolute | Voting Rights in % |
|---|---|---|---|---|---|
| Total: |
8. Information in relation to the person subject to the notification obligation
Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity
| Name | % of voting rights (if at least 3% or more) | % of voting rights through instruments (if at least 5% or more) | Total of both (if at least 5% or more) |
|---|---|---|---|
| Aviva Plc. | |||
| Aviva Group Holdings Limited | |||
| Aviva Life Holdings UK Limited | |||
| Aviva Life & Pensions UK Limited | |||
| -- | |||
| Aviva Plc. | |||
| Aviva Group Holdings Limited | |||
| Aviva Investors Holdings Limited | |||
| Aviva Investors Global Services Limited |
9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)
Date of general meeting: N/A
Holding total positions (6.) after general meeting:
| Proportion of voting rights | Proportion of instruments | Total of both |
|---|---|---|
| % | % | % |
10. Other useful information
Date
17.11.2020
(end)
| Emitter: |
Medigene AG Lochhamer Straße 11 82152 Planegg/Martinsried Germany |
|
|---|---|---|
| Contact Person: | Medigene PR/IR | |
| Phone: | +49 89 2000 3333 01 | |
| E-Mail: | investor@medigene.com | |
| Website: | www.medigene.de | |
| ISIN(s): | DE000A1X3W00 (Share) | |
| Stock Exchange(s): | Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate |